HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin-Ichiro Miura Selected Research

Catheters

11/2022Angiographic findings and treatment of coronary sinus spasm during left ventricular lead placement: A case report.
4/2021Combination of Linagliptin and Empagliflozin Preserves Cardiac Systolic Function in an Ischemia-Reperfusion Injury Mice With Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin-Ichiro Miura Research Topics

Disease

29Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 06/2003
16Hypertension (High Blood Pressure)
04/2024 - 12/2013
16Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 01/2008
11Heart Failure
01/2023 - 10/2015
9Atherosclerosis
12/2023 - 06/2009
8Myocardial Infarction
02/2023 - 10/2013
6Type 2 Diabetes Mellitus (MODY)
11/2023 - 03/2017
6Dyslipidemias (Dyslipidemia)
04/2021 - 10/2019
5Body Weight (Weight, Body)
05/2024 - 01/2015
5Inflammation (Inflammations)
03/2023 - 03/2009
5Acute Coronary Syndrome
11/2020 - 01/2005
5Pathologic Constriction (Stenosis)
01/2017 - 06/2009
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 10/2016
4Thrombosis (Thrombus)
08/2020 - 10/2011
4Essential Hypertension
01/2020 - 01/2010
4Stable Angina
02/2018 - 11/2011
3Coronary Stenosis (Coronary Artery Stenosis)
04/2024 - 01/2016
3Chest Pain (Chest Pains)
01/2022 - 04/2012
3Diabetes Mellitus
10/2021 - 08/2016
3Ischemic Stroke
10/2021 - 10/2020
3Reperfusion Injury
04/2021 - 02/2010
3Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 04/2019
3Coronary Restenosis
08/2016 - 01/2005
2ST Elevation Myocardial Infarction
02/2022 - 11/2020
2Obesity
11/2021 - 04/2019
2Cardiomegaly (Heart Hypertrophy)
12/2020 - 10/2009
2Atherosclerotic Plaque (Atheroma)
10/2020 - 01/2017
2Fibrosis (Cirrhosis)
07/2019 - 01/2016
2Renal Insufficiency (Renal Failure)
01/2019 - 01/2010
2Myocardial Reperfusion Injury
10/2016 - 01/2016
1Atrial Fibrillation
12/2023
1Chronic Pancreatitis
02/2023
1Neoplasms (Cancer)
02/2023
1Pancreatic Cyst
02/2023
1Gallbladder Neoplasms (Gallbladder Cancer)
02/2023
1Pancreatic Diseases (Pancreatic Disease)
02/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2023
1Left Ventricular Dysfunction
01/2023

Drug/Important Bio-Agent (IBA)

13Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024 - 01/2005
11LipidsIBA
01/2023 - 03/2009
9CholesterolIBA
01/2023 - 06/2009
8oxidized low density lipoproteinIBA
04/2024 - 06/2009
8LDL CholesterolIBA
04/2021 - 06/2009
7HDL LipoproteinsIBA
08/2023 - 03/2009
6omega-Chloroacetophenone (Mace)IBA
09/2023 - 02/2015
6Triglycerides (Triacylglycerol)IBA
01/2023 - 06/2009
6HDL CholesterolIBA
02/2021 - 06/2009
6Angiotensin IIIBA
12/2020 - 10/2009
6Valsartan (Vals)FDA Link
12/2020 - 01/2008
6Angiotensin II Type 1 Receptor BlockersIBA
01/2020 - 01/2008
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 - 12/2013
4Uric Acid (Urate)IBA
12/2023 - 01/2016
4AnticoagulantsIBA
08/2020 - 01/2016
4olmesartanIBA
05/2017 - 07/2009
3Antihypertensive Agents (Antihypertensives)IBA
04/2024 - 07/2009
3MetalsIBA
02/2021 - 01/2008
3Hemoglobins (Hemoglobin)IBA
02/2021 - 06/2009
3sacubitril and valsartan sodium hydrate drug combinationIBA
12/2020 - 01/2016
3Neprilysin (Neutral Endopeptidase)IBA
12/2020 - 01/2016
3RivaroxabanIBA
08/2020 - 10/2016
3Amlodipine (Norvasc)FDA LinkGeneric
04/2019 - 10/2015
3Biomarkers (Surrogate Marker)IBA
12/2017 - 09/2011
3AdiponectinIBA
11/2015 - 06/2009
2SodiumIBA
11/2023 - 11/2016
2Glucose (Dextrose)FDA LinkGeneric
11/2023 - 03/2009
2C-Reactive ProteinIBA
03/2023 - 11/2015
2Blood Glucose (Blood Sugar)IBA
04/2021 - 02/2021
2EnalaprilFDA LinkGeneric
12/2020 - 11/2016
2Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2020 - 01/2016
2Ezetimibe (Zetia)FDA Link
11/2020 - 10/2019
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2020 - 01/2020
2ApolipoproteinsIBA
11/2020 - 09/2014
2high density lipoprotein binding proteinIBA
11/2020 - 01/2020
2TolvaptanFDA Link
01/2019 - 05/2017
2EnzymesIBA
03/2018 - 05/2017
2Angiotensin Receptor AntagonistsIBA
05/2017 - 10/2016
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2017 - 06/2003
2Vitamin KFDA Link
03/2017 - 12/2016
2Hydrochlorothiazide (Esidrix)FDA LinkGeneric
02/2017 - 12/2015
2Peptides (Polypeptides)IBA
03/2016 - 09/2014
2Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2016 - 09/2014
2PTX3 proteinIBA
11/2015 - 08/2012
1Oxygen (Dioxygen)IBA
05/2024
1PolyaminesIBA
02/2023
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2023
1Sitagliptin Phosphate (Januvia)FDA Link
01/2023

Therapy/Procedure

19Therapeutics
02/2022 - 01/2005
13Cardiac Rehabilitation
02/2023 - 10/2015
9Stents
02/2021 - 01/2005
6Percutaneous Coronary Intervention
10/2020 - 11/2011
3Secondary Prevention
12/2020 - 10/2016
3Aftercare (After-Treatment)
05/2017 - 04/2012
2Denervation
04/2024 - 04/2024
2Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
11/2022 - 02/2020
2Catheters
11/2022 - 04/2021
2Renal Dialysis (Hemodialysis)
02/2021 - 02/2018
2Drug-Eluting Stents
02/2021 - 08/2016
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2012 - 10/2011
1Telerehabilitation
01/2023
1Patient Readmission
01/2023